Paper39100229
When does antimicrobial resistance increase bacterial fitness? Effects of dosing, social interactions, and frequency dependence on the benefits of AmpC β-lactamases in broth, biofilms, and a gut infection model.
Penkova E and 1 other. Evol Lett, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. When does antimicrobial resistance increase bacterial fitness? Effects of dosing, social interactions, and frequency dependence on the benefits of AmpC β-lactamases in broth, biofilms, and a gut infection model. Papers, record 39100229. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39100229
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
When does antimicrobial resistance increase bacterial fitness? Effects of dosing, social interactions, and frequency dependence on the benefits of AmpC β-lactamases in broth, biofilms, and a gut infection model.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References75
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30647458 | Bacterial persistence promotes the evolution of antibiotic resistance by increasing survival and mutation rates. | ISME J | 2019 | https://conductscience.org/library/papers/30647458 | PubMed |
| 2 | 11553456 | The rise and fall of antimicrobial resistance. | Trends Microbiol | 2001 | https://conductscience.org/library/papers/11553456 | PubMed |
| 3 | 36296347 | Long-Term Effects of Single-Dose Cephalosporin or Macrolide Use on the Prevalence of AmpC and Extended-Spectrum β-Lactamase Producing Escherichia coli in the Feces of Beef Cattle. | Microorganisms | 2022 | https://conductscience.org/library/papers/36296347 | PubMed |
| 4 | 15956430 | Gene mutations responsible for overexpression of AmpC beta-lactamase in some clinical isolates of Enterobacter cloacae. | J Clin Microbiol | 2005 | https://conductscience.org/library/papers/15956430 | PubMed |
| 5 | 23917989 | Bacterial cheating drives the population dynamics of cooperative antibiotic resistance plasmids. | Mol Syst Biol | 2013 | https://conductscience.org/library/papers/23917989 | PubMed |
| 6 | 27895008 | De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro. | Antimicrob Agents Chemother | 2017 | https://conductscience.org/library/papers/27895008 | PubMed |
| 7 | 30352641 | Antimicrobial resistance surveillance in Europe and beyond. | Euro Surveill | 2018 | https://conductscience.org/library/papers/30352641 | PubMed |
| 8 | 31384011 | Selection for antimicrobial resistance is reduced when embedded in a natural microbial community. | ISME J | 2019 | https://conductscience.org/library/papers/31384011 | PubMed |
| 9 | 26125685 | Making pathogens sociable: the [corrected] emergence of high relatedness through limited host invasibility. | ISME J | 2015 | https://conductscience.org/library/papers/26125685 | PubMed |
| 10 | 19940002 | What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae? | J R Soc Interface | 2010 | https://conductscience.org/library/papers/19940002 | PubMed |
| 11 | 10681318 | ampR gene mutations that greatly increase class C beta-lactamase activity in Enterobacter cloacae. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10681318 | PubMed |
| 12 | 32661001 | Strong Environment-Genotype Interactions Determine the Fitness Costs of Antibiotic Resistance In Vitro and in an Insect Model of Infection. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/32661001 | PubMed |
| 13 | 3539006 | Antibiotic tolerance among clinical isolates of bacteria. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3539006 | PubMed |
| 14 | 15875573 | Group-beneficial traits, frequency-dependent selection and genotypic diversity: an antibiotic resistance paradigm. | Proc Biol Sci | 2005 | https://conductscience.org/library/papers/15875573 | PubMed |
| 15 | 25308072 | The social biology of quorum sensing in a naturalistic host pathogen system. | Curr Biol | 2014 | https://conductscience.org/library/papers/25308072 | PubMed |
| 16 | 25271119 | Collective antibiotic resistance: mechanisms and implications. | Curr Opin Microbiol | 2014 | https://conductscience.org/library/papers/25271119 | PubMed |
| 17 | 28096340 | Evolution of antibiotic resistance is linked to any genetic mechanism affecting bacterial duration of carriage. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28096340 | PubMed |
| 18 | 31506315 | Antibiotics: Combatting Tolerance To Stop Resistance. | mBio | 2019 | https://conductscience.org/library/papers/31506315 | PubMed |
| 19 | 24395228 | Low or high doses of cefquinome targeting low or high bacterial inocula cure Klebsiella pneumoniae lung infections but differentially impact the levels of antibiotic resistance in fecal flora. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/24395228 | PubMed |
| 20 | 3931319 | The action of antituberculosis drugs in short-course chemotherapy. | Tubercle | 1985 | https://conductscience.org/library/papers/3931319 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42579328 | Microbial interactions as key players shaping the emergence and spread of de novo resistance mutations. | Microbiology (Reading) | 2026 | https://conductscience.org/library/papers/42579328 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39100229
GET https://conductscience.org/api/papers/v1/39100229/references?page=2